Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat

This publication has 41 references indexed in Scilit:

• Molecular Plasticity of Vascular Wall During N ^G -Nitro- l -Arginine Methyl Ester–Induced Hypertension
  Hypertension, 2000
• Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy
  The Lancet, 1996
• Anthracyclines and the heart.
  Heart, 1993
• Etiology of sarcoplasmic reticulum calcium release channel lesions in doxorubicin-induced cardiomyopathy
  Toxicology, 1992
• Alterations of Intracellular Calcium Homeostasis and Myocardial Energetics in Acute Adriamycin-Induced Heart Failure
  Journal of Cardiovascular Pharmacology, 1991
• Involvement of the Renin–Angiotensin System in Ischemic Damage and Reperfusion Arrhythmias in the Isolated Perfused Rat Heart
  Journal of Cardiovascular Pharmacology, 1991
• Current Status of Epirubicin (Farmorubicin) in the Treatment of Solid Tumours
  Acta Oncologica, 1990
• Preclinical Pharmacology of Zofenopril, an Inhibitor of Angiotensin I Converting Enzyme
  Journal of Cardiovascular Pharmacology, 1989
• Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat
  Journal of Molecular and Cellular Cardiology, 1987
• Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs
  The American Journal of Cardiology, 1985